MIHAI GHEORGHE

Dr. MIHAI GHEORGHE

First Obstetrics and Gynecology Clinic, University of Medicine, Pharmacy, Science and Technology “G.E. Palade” of Târgu Mures, 540142 Târgu Mures, Romania

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2021 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
GSGloria Salvo
Gloria Salvo
PRPedro T. Ramirez
Pedro T. Ramirez
MLMario M. Leitao
Mario M. Leitao
DCDavid Cibula
David Cibula
XWXiaohua Wu
Xiaohua Wu
RPRene Pareja
Rene Pareja

26 July 2021 in Experimental and Therapeutic Medicine
Verified
Journal Article
Open access
PDF file
MGMIHAI GHEORGHE
MIHAI GHEORGHE
ACAlexandra Lavinia Cozlea
Alexandra Lavinia Cozlea
SKSzilard Leo Kiss
Szilard Leo Kiss
MSMihai Stanca
Mihai Stanca
MCMihai Emil Căpîlna
Mihai Emil Căpîlna
AMAndreea Anamaria Moldovan
Andreea Anamaria Moldovan
This study was designed with an aim to share our experience of primary pelvic exenterations. The study included 23 patients with different types of pelvic cancer enrolled at a single institution between November 2011 and July 2020. The patient mean age was 55 years (range, 43‑72 years) and the oncological indications included: Stage IVa cervical cancer (11 cases, 48.9%), stage IVa endometrial cancer (1 case, 4.3%), stage IVa vaginal cancer (6 cases, 26%), stage IIIb bladder cancer (3 cases, 13%), stage IIIc rectal cancer (1 case, 4.3%) and undifferentiated pelvic sarcoma (1 case, 4.3%). Total, anterior, and posterior pelvic exenterations were performed on 34.4, 56.5 and 13% of cases, respectively. Related to levator ani muscle, 13 (56.5%) pelvic exenterations were supralevatorian, 10 (43.5%) infralevatorian, and 5 (21.7%) were infralevatorian with vulvectomy. No major intraoperative complications occurred. Seven patients (30.5%) developed early complications, 4 of them (17.4%) required reoperation and 1 (4.3%) perioperative death caused by a pulmonary embolism was recorded. Only 1 patient experienced a late complication, a urostomy stenosis. Over a median follow‑up period of 35 months, 8 (34.8%) patients died. The median overall survival (OS) was 33 months (range, 1‑96 months). The 2‑year and 5‑year survival rates were 72 and 66%, respectively. Primary pelvic exenteration may be related with various postoperative complications, without high perioperative morality and with long‑term survival.

15 September 2021 in Obstetrics & Gynecology Science
Verified
Journal Article
Open access
PDF file
Mihai CapilnaMihai Capilna
Mihai Capilna
LULászlo Ungár
Lászlo Ungár
ACAlexandra Lavinia Cozlea
Alexandra Lavinia Cozlea
MGMIHAI GHEORGHE
MIHAI GHEORGHE
Mihai StancaMihai Stanca
Mihai Stanca
AMAndreea Anamaria Moldovan
Andreea Anamaria Moldovan
Objective To describe the laterally extended parametrectomy (LEP) surgical technique, emphasizing the main challenges of the procedure.Methods LEP was designed as a more radical surgical procedure aiming to remove the entire parametrial tissue from the pelvic sidewall. Its initial indications were for lymph node positive Stage Ib (current International Federation of Gynecology and Obstetrics 2018 Stage IIIc) and Stage IIb cervical cancer. Currently, with most guidelines recommending definitive radiochemotherapy for these cases, initial LEP indications have become debatable. LEP is now mainly indicated for removing tumors involving the soft structures of the pelvic sidewall during a pelvic exenteration, aiming to obtain lateral free margins. This expands the lateral borders of the dissection to not only the medial surface of internal iliac vessels, but also to the true limits of the pelvic sidewall.Results During LEP, the parietal and visceral branches of the hypogastric vessels are divided at the entry and exit level of the pelvis. Consequently, the entire internal iliac system is excised, and no connective or lymphatic tissue remain on the pelvic sidewall. The main technical challenges of LEP are caused by the difficulty in ligating large caliber vessels (internal iliac artery and vein) and the variable anatomic distribution of pelvic sidewall veins.Conclusion LEP is a feasible technique for removing pelvic sidewall recurrences, aiming to obtain surgical free margins.

Verified
Journal Article
Open access
PDF file
Mihai StancaMihai Stanca
Mihai Stanca
VCVictoria Ciobanu
Victoria Ciobanu
MGMIHAI GHEORGHE
MIHAI GHEORGHE
SKSzilard Leo Kiss
Szilard Leo Kiss
ACAlexandra Lavinia Cozlea
Alexandra Lavinia Cozlea
Mihai CapilnaMihai Capilna
Mihai Capilna
(1) Background: Cervical cancer is the most common type of cancer encountered during pregnancy, with a frequency of 0.8–1.5 cases per 10,000 births. It is a dire condition endangering patients’ lives and pregnancy outcomes, and jeopardizing their fertility. However, there is a lack of current evidence and consensus regarding a standard surgical technique for pregnant patients who suffer from this condition during pregnancy. The study aims to comprehensively update all published data, evaluating the obstetrical and oncological results of pregnant patients who underwent abdominal radical trachelectomy during early stages of cervical cancer. (2) Methods: A literature search on the Medline, PubMed, and Google Scholar databases was performed, including all articles in question up to July 2020. This study presents an overview of the literature and our institutional experience. (3) Results: A total of 25 cases of abdominal radical trachelectomy were performed during pregnancy for early cervical cancer, including the five cases managed by the authors. Of these, 81% (19 patients) gave birth to live newborns through elective C-section, and 19% (6 patients) experienced miscarriage shortly after the procedure. None of the 25 patients (100%) reported disease recurrence. (4) Conclusions: The results of the current study were satisfactory. However, abdominal radical trachelectomy does not represent the current standard of care for cervical cancer during pregnancy, but it could play an important role if more evidence on its effectiveness will be provided.

1 January 2020 in European Journal of Gynaecological Oncology
Verified
Journal Article
Closed access
PDF file
MCM.E. Căpîlna
M.E. Căpîlna
BSB. Szabo
B. Szabo
JBJ. Becsi
J. Becsi
MMM. Morariu
M. Morariu
MGMIHAI GHEORGHE
MIHAI GHEORGHE
BMB. Moldovan
B. Moldovan

17 February 2021 in Research Square
Verified
Preprint
Open access
PDF file
MGMIHAI GHEORGHE
MIHAI GHEORGHE
SKSzilard Leo Kiss
Szilard Leo Kiss
MSMihai Stanca
Mihai Stanca
RBRadu Florian Bobes
Radu Florian Bobes
ACAlexandra Lavinia Cozlea
Alexandra Lavinia Cozlea
AMAndreea Anamaria Moldovan
Andreea Anamaria Moldovan
Background: Pelvic exenteration can be performed in selected patients with large pelvic malignancies as a primary treatment with curative intention. This study aimed to share our experience of primary pelvic exenterations, which were performed in a single institution between November 2011 and July 2020, enroling 23 patients with different types of pelvic cancers.Results: The patients mean age was 55 years (range: 43-72 years) and the oncological indications were: stage IVa cervical cancer (11 cases, 48.9%), stage IVa endometrial cancer (1 case, 4.3 %), stage IVa vaginal cancer (6 cases, 26%), stage IIIb bladder cancer (3 cases, 13%), stage IIIc rectal cancer (1 case, 4.3%) and undifferentiated pelvic sarcoma (1 case, 4.3%). Total, anterior, and posterior pelvic exenterations have consisted of 34.4%, 56.5% and 13% of cases, respectively. Related to levator ani muscle, 13 (56.5%) pelvic exenterations were supralevatorian, 10(43.5%) infralevatorian, and 5 (21.7%) were infralevatorian with vulvectomy. No major intraoperative complications have occured. Seven patients (30.5%) have developed early complications, and 4 of them (17.4%) have required reoperation. One (4.3 %) perioperative death caused by a pulmonary embolism was recorded and one patient had a late complication represented by a urostomy stenosis. Over a median follow-up period of 35 months, 8 (34.8%) patients have died. The median overall survival (OS) was 33 months (range 1-96 months). The 2-year and 5-year survival rates were 72% and 66% respectively. Univariate analysis showed that margin status was the only factor significantly associated with disease-free survival (DFS) (p=0.016). Conclusion: Primary pelvic exenteration can be related with various postoperative complications, without high perioperative morality and with long-term survival.